Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
JAMA Oncology Author Interviews
00:00
The Importance of Postoperative Therapy in Pancreatic Cancer
Dr. West: How common is it to deliver postoperative therapy and how feasible is it, especially after the rigors of pancreatic surgery? He says a significant number of patients cannot receive edge-of-ant treatment in the right timing after surgery because it's too tired or not fit enough. "There is a shift in many centers to really giving new eye-to-one to everyone," he says.
Play episode from 02:47
Transcript


